Erythrocyte-bound apolipoprotein B after withdrawal of statin therapy

Completed

• Conditions: hypercholesterolemie; Hypercholesterolemia; 10003216

• Registration Number: NL-OMON38118
• Lead Sponsor: Sint Franciscus Gasthuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 53

Inclusion Criteria

Aged 18 years or older
Use of statin therapy

Exclusion Criteria

A cardiovascular event (myocardial infarction, percutaneous coronary intervention or stroke) in the past 6 months.
The use of any other lipid lowering drugs besides a statin, for example ezetimibe or a fibrate in the past 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Erythrocyte-bound apolipoprotein B before and after discontinuation of statin<br /><br>therapy.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>